Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)

China flag China · Delayed Price · Currency is CNY
81.45
+0.74 (0.92%)
Apr 29, 2026, 4:00 PM EDT
281.32%
Market Cap 6.43B
Revenue (ttm) 154.18M
Net Income (ttm) -102.17M
Shares Out 78.96M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,585,100
Average Volume 2,366,261
Open 79.87
Previous Close 80.71
Day's Range 76.01 - 83.13
52-Week Range 21.04 - 98.29
Beta 0.42
RSI 62.43
Earnings Date Apr 29, 2026

About SHE:301075

Tibet Duo Rui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, intermediates, and raw materials in China. It offers fluid therapy, anesthesiology medication, analgesic medication, and first-aid medication products, as well as sodium acetate ringer's injection; and agent products, such as amoxicillin sodium and clavulanate potassium for injection, etc. The company was founded in 2005 and is headquartered in Tibet, China. [Read more]

Sector Healthcare
Founded 2005
Employees 497
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301075
Full Company Profile

Financial Performance

In 2025, SHE:301075's revenue was 154.18 million, a decrease of -35.93% compared to the previous year's 240.63 million. Losses were -102.17 million, 63.0% more than in 2024.

Financial Statements

News

There is no news available yet.